Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Robinson Chandler
Over the trailing 90 days, Robinson Chandler (Director at Monopar Therapeutics) sold $378K of stock in MNPR, per 3 SEC Form 4 transactions.
- Role
- Director
- Companies
- MNPR
- Window
- Trailing 90 days · 3 transactions · CIK 1727334
- Net activity
- −$378K ($0 bought · $378K sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| MNPR | Monopar Therapeutics | 3 | — | $378K | −$378K |
Transactions (3)
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Robinson's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.